Skip to main content

Table 2 Comparison between the tumor recurrence group and group with no tumor recurrence regarding pre- and post-radiofrequency TGFB1, AFP, and AFP-L3%

From: α-Fetoprotein (AFP)-L3% and transforming growth factor B1 (TGFB1) in prognosis of hepatocellular carcinoma after radiofrequency

 

Tumor recurrence

t test

Yes

No

Mean ± SD

Mean ± SD

t

p value

Pre-TGFB1(ng/mL)

62.70 ± 24.75

63.33 ± 23.76

− 0.064

0.950

Post-TGFB1(ng/mL)

66.72 ± 16.08

54.37 ± 25.42

1.227

0.228

p value

0.461

< 0.001

  

Pre-AFP (ng/mL)

91.97 ± 63.07

83.92 ± 62.21

0.310

0.758

Post-AFP (ng/mL)

66.91 ± 36.37

42.89 ± 30.16

1.849

0.072

p value

0.093

< 0.001

  

Pre-AFP-L3%

35.53 ± 15.68

27.07 ± 12.29

1.577

0.123

Post-AFP-L3%

53.10 ± 15.03

1.56 ± 2.53

19.322

< 0.001

p value

0.036

< 0.001